Differential Modulation of Caveolin-1 Expression in Cells of the Vasculature by Statins
Authors:
- 20 January 2004
- journal article
- letter
- Published by Wolters Kluwer Health in Circulation
- Vol. 109 (2) , e7-8
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Cholesterol transporter caveolin‐1 transits the lipid bilayer during intracellular cyclingThe FASEB Journal, 2003
- Rosuvastatin Decreases Caveolin-1 and Improves Nitric Oxide–Dependent Heart Rate and Blood Pressure Variability in Apolipoprotein E −/− Mice In VivoCirculation, 2003
- Hydroxy-Methylglutaryl–Coenzyme A Reductase Inhibition Promotes Endothelial Nitric Oxide Synthase Activation Through a Decrease in Caveolin AbundanceCirculation, 2001
- Differences in Caveolae Dynamics in Vascular Smooth Muscle Cells of Different PhenotypesLaboratory Investigation, 2000
- Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthaseJournal of Clinical Investigation, 1999
- Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayersProceedings of the National Academy of Sciences, 1997